About Incite Health Life Sciences
Incite Health Life Sciences is a private company based in Doylestown, Pennsylvania. It has reported $1,735,666 raised in three offerings on Form D since January 2017. Its chief executive is Renold Capocasale.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 5, 2025 | May 22, 2025 | $330,666of $2.0M target | 3 | $110K | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Mar 29, 2019 | Apr 15, 2019 | $585,000of $1.2M target | 6 | $97,500 | Equity, OptionsRule 506(b) | Form D ↗ |
| Jan 5, 2017 | Jan 20, 2017 | $820,000of $2.0M target | 8 | $102K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $1,735,666 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Incite Health Life Sciences's Form D filed May 22, 2025.
Earlier filings also listed Ward Wilday (director, last listed Apr 2019), Raymond Douglas (director, last listed Apr 2019), Martin Smith (director, last listed Apr 2019), Loretta Joseph (director, last listed Apr 2019), Jonni Moore (director, last listed Apr 2019), John Healey (executive officer and director, last listed Apr 2019), Eric Halberg (director, last listed Apr 2019) and Edward Giles, Jr. (executive officer, last listed Apr 2019).